# Clopidogrel With Aspirin in High-risk Patients With Acute Non-disabling Cerebrovascular Events II

> **NCT04078737** · PHASE3 · COMPLETED · sponsor: **Beijing Tiantan Hospital** · enrollment: 6412 (actual)

## Conditions studied

- Stroke
- Transient Ischemic Attack

## Interventions

- **DRUG:** Ticagrelor and Aspirin
- **DRUG:** Clopidogrel and Aspirin

## Key facts

- **NCT ID:** NCT04078737
- **Lead sponsor:** Beijing Tiantan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-23
- **Primary completion:** 2021-06-24
- **Final completion:** 2021-07-01
- **Target enrollment:** 6412 (ACTUAL)
- **Last updated:** 2021-12-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04078737

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04078737, "Clopidogrel With Aspirin in High-risk Patients With Acute Non-disabling Cerebrovascular Events II". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04078737. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*